BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18716553)

  • 1. Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.
    Snuderl M; Chi SN; De Santis SM; Stemmer-Rachamimov AO; Betensky RA; De Girolami U; Kieran MW
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):911-20. PubMed ID: 18716553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nestin expression identifies ependymoma patients with poor outcome.
    Milde T; Hielscher T; Witt H; Kool M; Mack SC; Deubzer HE; Oehme I; Lodrini M; Benner A; Taylor MD; von Deimling A; Kulozik AE; Pfister SM; Witt O; Korshunov A
    Brain Pathol; 2012 Nov; 22(6):848-60. PubMed ID: 22568867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.
    Cage TA; Clark AJ; Aranda D; Gupta N; Sun PP; Parsa AT; Auguste KI
    J Neurosurg Pediatr; 2013 Jun; 11(6):673-81. PubMed ID: 23540528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer.
    Schwandner O; Schlamp A; Broll R; Bruch HP
    Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic marker analysis in pediatric intracranial ependymomas.
    McLendon RE; Lipp E; Satterfield D; Ehinger M; Austin A; Fleming D; Perkinson K; Lefaivre M; Zagzag D; Wiener B; Gururangan S; Fuchs H; Friedman HS; Herndon JE; Healy P
    J Neurooncol; 2015 Apr; 122(2):255-61. PubMed ID: 25563815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
    Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
    Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
    Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
    Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma.
    Ridley L; Rahman R; Brundler MA; Ellison D; Lowe J; Robson K; Prebble E; Luckett I; Gilbertson RJ; Parkes S; Rand V; Coyle B; Grundy RG;
    Neuro Oncol; 2008 Oct; 10(5):675-89. PubMed ID: 18701711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis by tumor location for pediatric spinal cord ependymomas.
    Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
    J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
    Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
    J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors in intracranial ependymomas in children.
    Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
    J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.
    Hongo H; Takai K; Komori T; Taniguchi M
    J Neurosurg Spine; 2018 Oct; 30(1):133-139. PubMed ID: 30485241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
    Lin Y; Jea A; Melkonian SC; Lam S
    J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PI3K pathway activation provides a novel therapeutic target for pediatric ependymoma and is an independent marker of progression-free survival.
    Rogers HA; Mayne C; Chapman RJ; Kilday JP; Coyle B; Grundy RG
    Clin Cancer Res; 2013 Dec; 19(23):6450-60. PubMed ID: 24077346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
    Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
    PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
    Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
    J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.
    Robertson PL; Zeltzer PM; Boyett JM; Rorke LB; Allen JC; Geyer JR; Stanley P; Li H; Albright AL; McGuire-Cullen P; Finlay JL; Stevens KR; Milstein JM; Packer RJ; Wisoff J
    J Neurosurg; 1998 Apr; 88(4):695-703. PubMed ID: 9525716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
    de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
    Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma.
    Jin Y; Liang ZY; Zhou WX; Zhou L
    Pathology; 2020 Apr; 52(3):359-365. PubMed ID: 32122646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.